Skip to main content
Digital Seminar

The Fantastic Effects of Ketamine Assisted Psychotherapy: A Revolution in Clinical Practice

Phil Wolfson, MD
1 Hour
Audio and Video
Jul 28, 2022
Product Code:
Media Type:
Digital Seminar
Never expires.


Just as the assessment is an important part of Psychedelic-Assisted Psychotherapy (PAP), the integration after PAP treatment is even more important.  

Several key elements are involved in strategic integration in an attempt to avoid influencing or fulfilling the therapist’s agenda above what is important to the patient.  

Ketamine has been used legally for depression, anxiety, and a host of other mental health conditions.  This recording reviews the key elements of integration strategies specific to the mental health condition being addressed.  Ketamine treatment has some specific nuances that will be outlined and compared to other psychedelics.  

Ways to improve the efficacy of the integration are described with specific case examples to highlight tools to improve outcome.  

Viewers will leave with an understanding as to when ketamine assisted psychotherapy might be beneficial to specific patients.


Planning Committee Disclosure - No relevant relationships All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners. For speaker disclosures, please see the faculty biography.


PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This program is worth 1 hours CPD for points calculation by your association.



Phil Wolfson, MD's Profile

Phil Wolfson, MD Related seminars and products

Phil Wolfson, MD, is president and CEO of the non-profit Ketamine Research Foundation and directs the training of KAP practitioners through The Ketamine Center. Phil’s book, The Ketamine Papers, is the seminal work in the burgeoning ketamine arena. He is principal investigator for the MAPS sponsored Phase 2, the FDA-approved 18-person study of MDMA-Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine-Assisted Psychotherapy.

Speaker Disclosures:
Financial: Philip Wolfson is the founder and CEO of The Ketamine Research Foundation. He has an ownership interest in Progressive Therapeutics, Inc. Dr. Wolfson will address off-label uses. He has no relevant financial relationships with ineligible organizations.
Non-financial: Philip Wolfson has no relevant non-financial relationship to disclose.


  1. Analyze the signature reactions and internal experiences specific to ketamine assisted psychotherapy (KAP).  
  2. Determine the key reactions to ketamine assisted psychotherapy experienced by a majority of clients as it relates to changes to their ego state and consciousness, both before, during, and after treatment with ketamine.  
  3. Categorize the stages of KAP as well as ways clinicians can help clients integrate what is learned during the psychedelic experience post-KAP. 


  • Better understanding of KAP, including for awareness of when a referral might be needed and appropriate and understanding of the dimensions of integrating content from a KAP. 
  • Build awareness, and awakening being – and healing trauma experiences through connection, compassion, and sharing. 
  • Explore the role of emotional connection, and integration of emotional content therapeutically without the overshadowing of fear, anxiety and depression. 
  • Case illustrations of KAP 

Target Audience

  • Counsellors
  • Marriage & Family Therapists
  • Nurses
  • Nurse Practitioners
  • Physicians
  • Psychologists
  • Social Workers
  • Other Behavioral Health Professionals

Please wait ...

Back to Top